JP2025512583A5 - - Google Patents
Info
- Publication number
- JP2025512583A5 JP2025512583A5 JP2024562812A JP2024562812A JP2025512583A5 JP 2025512583 A5 JP2025512583 A5 JP 2025512583A5 JP 2024562812 A JP2024562812 A JP 2024562812A JP 2024562812 A JP2024562812 A JP 2024562812A JP 2025512583 A5 JP2025512583 A5 JP 2025512583A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- pharmaceutical composition
- organic solvent
- filler
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22170407.5 | 2022-04-28 | ||
| EP22170407 | 2022-04-28 | ||
| PCT/EP2023/061060 WO2023209062A1 (en) | 2022-04-28 | 2023-04-27 | Solid form of 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9- tetrahydro-2h-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol tartrate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512583A JP2025512583A (ja) | 2025-04-17 |
| JP2025512583A5 true JP2025512583A5 (https=) | 2026-05-07 |
Family
ID=81392840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024562812A Pending JP2025512583A (ja) | 2022-04-28 | 2023-04-27 | ３－（（１Ｒ，３Ｒ）－１－（２，６－ジフルオロ－４－（（１－（３－フルオロプロピル）アゼチジン－３－イル）アミノ）フェニル）－３－メチル－１，３，４，９－テトラヒドロ－２Ｈ－ピリド［３，４－ｂ］インドール－２－イル）－２，２－ジフルオロプロパン－１－オール酒石酸塩の固体形態 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250282775A1 (https=) |
| EP (1) | EP4514792A1 (https=) |
| JP (1) | JP2025512583A (https=) |
| KR (1) | KR20250006222A (https=) |
| CN (1) | CN119156386A (https=) |
| AU (1) | AU2023262166A1 (https=) |
| CA (1) | CA3255956A1 (https=) |
| IL (1) | IL316096A (https=) |
| MX (1) | MX2024013116A (https=) |
| TW (1) | TW202400141A (https=) |
| WO (1) | WO2023209062A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202602868A (zh) * | 2024-04-15 | 2026-01-16 | 瑞士商諾華公司 | 瑞波西利的藥物組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI874834B (zh) | 2014-12-18 | 2025-03-01 | 瑞士商赫孚孟拉羅股份公司 | 四氫-吡啶并[3,4-b]吲哚雌激素受體調節劑及其用途 |
| CR20200621A (es) | 2018-06-21 | 2021-02-03 | Hoffmann La Roche | Formas sólidas de 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3 fluoropropil)azetidin-3-il)amino)fenil)-3-(metil-1,3,4,9-tetrahidro-2h-pirido[3,4-b]indol-2-il)-2,2-difluoropropan-1-ol y procesos para preparar compuestos tricíclicos fusionados que comprenden un resto fenilo o piridinilo sustituido, incluidos métodos para su uso |
-
2023
- 2023-04-27 AU AU2023262166A patent/AU2023262166A1/en active Pending
- 2023-04-27 CA CA3255956A patent/CA3255956A1/en active Pending
- 2023-04-27 TW TW112115780A patent/TW202400141A/zh unknown
- 2023-04-27 IL IL316096A patent/IL316096A/en unknown
- 2023-04-27 WO PCT/EP2023/061060 patent/WO2023209062A1/en not_active Ceased
- 2023-04-27 JP JP2024562812A patent/JP2025512583A/ja active Pending
- 2023-04-27 CN CN202380036684.8A patent/CN119156386A/zh active Pending
- 2023-04-27 KR KR1020247039066A patent/KR20250006222A/ko active Pending
- 2023-04-27 US US18/859,397 patent/US20250282775A1/en active Pending
- 2023-04-27 EP EP23722867.1A patent/EP4514792A1/en active Pending
-
2024
- 2024-10-24 MX MX2024013116A patent/MX2024013116A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5419866B2 (ja) | 新たな医薬組成物 | |
| US20070264330A1 (en) | Pharmaceutical formulations of pimavanserin | |
| US11883403B2 (en) | Pharmaceutical compositions comprising Afatinib | |
| JPWO1992021345A1 (ja) | 抗腫瘍効果増強のための及び腫瘍治療のための組成物 | |
| JP2023534322A5 (https=) | ||
| US20070048374A1 (en) | Bazedoxifene acetate formulations | |
| TWI794214B (zh) | 包含5-氯-n4-[2-(二甲基磷醯基)苯基]-n2-{2-甲氧基-4-[4-(4-甲基哌嗪-1-基)哌啶-1-基]苯基}嘧啶-2,4-二胺之醫藥調配物 | |
| JP2025512583A5 (https=) | ||
| US10696629B2 (en) | Crystalline form of dextral oxiracetam, preparation method therefor and use thereof | |
| JP2011511818A (ja) | フリバンセリンの製剤 | |
| CA2925960A1 (en) | Pharmaceutical composition comprising capecitabine and cyclophosphamide | |
| US10709691B2 (en) | Pharmaceutical dosage forms | |
| TWI720115B (zh) | 一種含有喹啉衍生物或其鹽的醫藥組成物的製備方法 | |
| TW202400141A (zh) | ３－（（１ｒ，３ｒ）－１－（２，６－二氟－４－（（１－（３－氟丙基）四氫吖唉－３－基）胺基）苯基）－３－甲基－１，３，４，９－四氫－２ｈ－吡啶并［３，４－ｂ］吲哚－２－基）－２，２－二氟丙－１－醇酒石酸鹽之固體形式 | |
| EP2677868B1 (en) | Pharmaceutical compositions of maraviroc and process for the preparation thereof | |
| RU2024129716A (ru) | ТВЕРДАЯ ФОРМА ТАРТРАТА 3-((1R,3R)-1-(2,6-ДИФТОР-4-((1-(3-ФТОРПРОПИЛ)АЗЕТИДИН-3- ИЛ)АМИНО)ФЕНИЛ)-3-МЕТИЛ-1,3,4,9-ТЕТРАГИДРО-2H-ПИРИДО[3,4-b]ИНДОЛ-2-ИЛ)-2,2- ДИФТОРПРОПАН-1-ОЛА | |
| US20200054621A1 (en) | Pharmaceutical compositions of pomalidomide | |
| EP3378478B1 (en) | Pharmaceutical composition comprising quinoline derivative or salt thereof | |
| TW200418486A (en) | Solid preparation | |
| CN121620362A (zh) | 包含n-[2-(3-氟-5-甲磺酰基苯氧基)乙基](丙基)胺的酒石酸盐的药物组合物 | |
| DE102010005124A1 (de) | Feste pharmazeutische Zusammensetzung umfassend Lercanidipin |